IncFact
Company Profiles: Revenue, Growth, Competition

RUBIUS THERAPEUTICS Revenue, Growth & Competitor Profile

Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Rubius Therapeutics

Access the complete profile.

Rubius Therapeutics Fast Facts

Revenue$50 - $100 million    See Exact Annual Revenue
Employees100 - 500Exact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes32541
Address325 Vassar Street
1a
Cambridge, MA 02139

Note: Revenues for privately held companies are statistical evaluations.


Rubius Therapeutics's annual revenues are $50-$100 million (see exact revenue data) and has 100-500 employees. It is classified as operating in the Medicinal & Botanical Manufacturing industry.


Rubius Therapeutics's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Rubius Therapeutics Annual Revenue and Growth Rate

Rubius Therapeutics Revenue Est.
($ Million)
Growth Rate (%)# Employees
2019 Details in Premium Report
2018
2017
2016
2015
2014


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Rubius Therapeutics's revenues are gauged from an analysis of company filings.



Investor Activity

Rubius Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
March 1, 2018 27 100%$101 MM
Complete list of funding rounds and total amounts in the Company Report




Rubius Therapeutics's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Rubius Therapeutics Revenue (Sales) Rubius Therapeutics Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Rubius Therapeutics is developing and marketing. Rubius Therapeutics's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
REALIZING THE POWER OF RED
Cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, and other diseases and disorders; pharmaceutical preparations of cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, and other diseases and disorders, namely, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders
02/14/2019
RTX
Cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, and other diseases and disorders, namely, central nervous system diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders
08/07/2018
RUBIUS THERAPEUTICS
cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, and other diseases and disorders
01/03/2017

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Rubius Therapeutics grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Rubius Therapeutics is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Medicinal & Botanical Manufacturing

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Rubius Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Rubius Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
PANACEA BIOMATXResearch Triangle Park, NC100 
TMUNITY THERAPEUTICSPhiladelphia, PA60 




Nearby Competitors

These companies are similar in business line and location to Rubius Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
ABCAMCambridge, MA100 
SAREPTA THERAPEUTICSCambridge, MA100 
BRAINTREE LABORATORIESBraintree, MA46 
FOGHORN THERAPEUTICSCambridge, MA36 
RUBIUS THERAPEUTICSCambridge, MA26 
SERVIER PHARMACEUTICALSBoston, MA20 




Future Competition: Rubius Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Rubius Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Rubius Therapeutics Competitors